SurgoCap Partners’s McKesson MCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285M Buy
376,870
+28,138
+8% +$22.3M 9.21% 6
2026
Q1
$302M Sell
348,732
-70,434
-17% -$62.9M 10.08% 5
2025
Q4
$344M Sell
419,166
-33,095
-7% -$27M 9.52% 4
2025
Q3
$349M Buy
452,261
+184,106
+69% +$130M 9.71% 2
2025
Q2
$196M Sell
268,155
-25,982
-9% -$18.3M 7.42% 8
2025
Q1
$198M Sell
294,137
-214,744
-42% -$133M 9.78% 4
2024
Q4
$290M Sell
508,881
-99,436
-16% -$55.7M 14.94% 1
2024
Q3
$301M Buy
608,317
+126,675
+26% +$70.5M 15.02% 1
2024
Q2
$281M Sell
481,642
-14,261
-3% -$7.94M 16.45% 1
2024
Q1
$266M Buy
495,903
+162,875
+49% +$82.7M 14.29% 1
2023
Q4
$154M Buy
+333,028
New +$151M 10.77% 2

Other funds holding MCK

SurgoCap Partners's MCK Position: Q2 2026 in Review

SurgoCap Partners increased its McKesson (MCK) stake by 8.1% in Q2 2026, buying an estimated $22.3M and bringing the position to 376,870 shares worth $285M. The position accounts for 9.21% of the portfolio, ranked #6.

SurgoCap Partners first reported a position in MCK in Q4 2023 and has held it in 11 quarters since. The position peaked at $349M in Q3 2025. 1,995 funds tracked by Wall St. Rank hold MCK as of Q2 2026.

  • SurgoCap Partners held 376,870 shares of McKesson worth $285M as of Q2 2026.
  • SurgoCap Partners bought 28,138 McKesson shares in Q2 2026, an estimated $22.3M.
  • McKesson made up 9.21% of SurgoCap Partners's portfolio in Q2 2026, its #6 holding.
  • SurgoCap Partners first reported a position in McKesson in Q4 2023 and has held it in 11 quarters since.
  • SurgoCap Partners's McKesson position peaked at $349M in Q3 2025.
  • 1,995 funds tracked by Wall St. Rank held McKesson as of Q2 2026.

Based on SurgoCap Partners's 13F filing for Q2 2026, filed 14 Aug 2026.